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. About 60% of human lung cancers contain mutations in the P53 tumor suppressor gene (3). The P53 mutation database (4) includes more than 500 entries of sequenced P53 mutations for lung cancer. There is a large percentage of G to T transversion mutations in these tumors. Such mutations are hallmarks of mutagenesis involving certain types of polycyclic aromatic hydrocarbons, including BPDE (5), but they can also be induced by other agents, including oxidative DNA damage (6). The distribution of mutations along the P53 gene in lung cancer is nonrandom but rather is characterized by several mutational hotspots, in particular, at codons 157, 248, and 273 (Fig. 1) , which correspond to ami- To investigate the relation between BPDE adduct formation and P53 mutations, we mapped the distribution of BPDE adducts along the P53 gene using a modification of the ligation-mediated polymerase chain reaction (LMPCR) (8). HeLa cells were treated with various concentrations of BPDE (9), and DNA was isolated and cleaved at the sites of modified bases with the UvrABC nuclease complex from Escherichia coli (10). UvrABC makes a dual incision 5' and 3' to the adducted base, and the 3' incision occurs specifically at the fourth nucleotide position 3' to a BPDE adduct (I 1). These break positions can then be visualized by LMPCR in which P53-specific oligonucleotide primers were used (12, 13). Figure 2A shows an analysis of the upper (nontranscribed) DNA strand of exon 5. One of the strongest BPDE-derived signals along the exon is seen at codon 157, which is one of the major mutational hotspots in lung cancer. In exon 7, the two guanine positions within the frequently mutated codon 248 are the preferred targets for BPDE adduct formation (Fig. 2B) . The same is true for exon 8, where the strongest signal corresponds to a BPDE adduct at the guanine within the mutational hotspot codon 273 (Fig. 2C) .
To analyze a cell type that is more representative of the target cell population during lung tissue transformation, we performed similar experiments with normal human bronchial epithelial cells (14 Fig. 3) . To test whether the sequence specificity is related to chromatin structure, we compared the adduct pattern in BPDE-treated HeLa cells with the pattern in BPDE-treated isolated genomic DNA. The two patterns were almost identical (15), which excludes chromatin structure as a major modulating factor for the cell types analyzed. It should be noted that the histogenesis of the different types of lung cancer is incompletely understood. Therefore, it is important that a similar adduct pattern was seen in three different cell types: HeLa cells (Fig.  2), bronchial cells (Fig. 3) , and normal human fibroblasts (15). This pattem does not appear to be greatly modified by cell type-specific chromatin structure, which suggests that the same adduct pattern is likely to be present in the unidentified target cells for lung tissue transformation. Strong selectivity of BPDE binding at guanine positions in codons 157, 248, and 273 was not observed in previous experiments in which a DNA polymerase fingerprint assay was used to detect adducts formed in carcinogen-treated plasmid DNA (16). The apparent discrepancies between our findings and those of this previous study could be due to different methylation patterns in E. coli versus human DNAs; however, the discrepancies may also arise from differences in specificity and sensitivity of the detection method.
The BPDE adduct hotspots are on the nontranscribed DNA strand, which is expected to be repaired relatively inefficiently, according to the concept of transcription-coupled repair (17, 18). A strand bias in repair is consistent with the majority (>90%) of G to T mutations in lung cancer attributable to guanines on the nontranscribed strand (3, 4) .
Codon 179, which is also frequently mutated in lung tumors, is not a strong target for BPDE adduct formation (Fig.  2A) . However, this codon does not contain a guanine on the nontranscribed strand, and the majority of mutations are A to G transitions at the second codon base (4). BPDE binds to guanine 20 times more efficiently than to adenine; thus, it is likely that these mutations are caused by another mutagenic component of cigarette smoke. Pronounced adduct formation was observed at codon 267 (Figs. 2C and 3C) , for which there is only one mutation entry in the P53 database. Here, the most strongly adducted base corresponds to the third codon position (CGG), and a mutation would not produce an amino acid change.
It has been generally assumed that P53 cancer mutations occur frequently at specific codons because they are selected for in the cell transformation process. One possibility is that mutational hotspot codons are sites of preferred gain of function mutations or sites that are most important for tumor suppressor function of the protein. The presence of mutational hotspots has been correlated with crystal structure data obtained from a p53 protein-DNA complex (19) . The most frequently mutated amino acids (residues 248 and 273) contact DNA directly, whereas some of the other commonly mutated amino acids contribute to stabilization of the protein (19). In lung cancers, mutations in the P53 gene are found at more than 100 different sequence positions (Fig. 1) , and it is likely that all of these mutations can provide a growth advantage. These results, together with our current finding that P53 mutation hotspots 157, 248, and 273 act as selective BPDE binding sites, suggest that P53 mutation hotspots are preferential targets for DNAdamaging agents and that selection may not necessarily play a major role in the occur- 
